Canadian pharmaceutical firms Nuvo Research and Apotex have agreed a patent settlement allowing Apotex to launch a generic version of Nuvo’s arthritis treatment PENNSAID in the US in April 2014 or earlier under certain circumstances.
If you have already subscribed please login.
If you have any technical issues please email tech support.
Nuvo Research, Apotex, PENNSAID, generics, patent settlement
